Nivolumab Combo for RCC Necessitates AE Monitoring, AwarenessByLaurence Albiges, MD, PhDFebruary 19th 2025According to Laurence Albiges, MD, PhD, treatment of RCC with cabozantinib, nivolumab, and ipilimumab can cause potentially serious toxicities that should be closely monitored.